Migration of lead in non-metamict zircon von Bogomolov, Ye.S.

Volltext

The nature of the basement in the Archaean Dharwar craton of southern India and the age of the Peninsular Gneiss von NAHA, K, SRINIVASAN, R, GOPALAN, K, PANTULU, G. V. C, SUBBA RAO, M. V, VREVSKY, A. B, BOGOMOLOV, YE. S

Volltext

Tracing Geographical Origins of Teas Based on FT-NIR Spectroscopy: Introduction of Model Updating and Imbalanced Data Handling Approaches von Yu, Xiao-Ping, Zhang, Li, Wang, Zheng-Liang, Fu, Xian-Shu, Hong, Xue-Zhen, Ye, Zi-Hong

Volltext

Sensitization to rye allergen in patients with allergic rhinitis and atopic bronchial asthma: comparison of the diagnostic parameters von Bogomolov, A. Ye

Volltext

Characteristic of nicotine delivery devices – electronic cigarettes – as a tool to fight against tobacco dependence von Bogomolov, A. Ye

Volltext

Thermal Capacity of Enriched Fuel Briquets Produced from the Fine of Ekibastuz Coal von Bykov, Petr O., Abdrakhmanov, Y.S., Bogomolov, Alexey V.

Volltext

GS-002 48-week off-therapy efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: final results from the phas... von Asselah, Tarik, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pantea, Victor, Lazar, Stefan, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Chee, Grace M., Da, Ben L., Lau, Audrey H., Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Zoulim, Fabien

Volltext

FRI-371 Undetectable HDV RNA at 24 weeks of treatment with combination therapy is an important predictor of maintained response off-therapy von Zoulim, Fabien, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pantea, Victor, Lazar, Stefan, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Chee, Grace M., Da, Ben L., Lau, Audrey H., Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Asselah, Tarik

Volltext

WED-395 Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic... von Zoulim, Fabien, Asselah, Tarik, Chulanov, Vladimir, Streinu-Cercel, Adrian, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Sagalova, Olga, Mercier, Renee-Claude, Ye, Lei, Manuilov, Dmitry, Lau, Audrey H., Chee, Grace M., Da, Ben L., Bourliere, Marc, Wedemeyer, Heiner, Lampertico, Pietro

Volltext

Integrated efficacy analysis of 24-week data from two phase 2 and one phase 3 clinical trials of bulevirtide monotherapy given at 2 mg or 10 mg dose level for treatment of chronic... von Lampertico, Pietro, Aleman, Soo, Blank, Antje, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Viacheslav, Morozov, Sagalova, Olga, Stepanova, Tatyana, Suri, Vithika, Manuilov, Dmitry, Ye, Lei, Flaherty, John F., Osinusi, Anu, Cornberg, Markus, Brunetto, Maurizia, Wedemeyer, Heiner

Volltext

Integrated safety analysis of 24-week data from three phase 2 and one phase 3 clinical trials of bulevirtide monotherapy given at 2 mg and 10 mg dose level for treatment of chronic... von Lampertico, Pietro, Aleman, Soo, Asselah, Tarik, Bourliere, Marc, Streinu-Cercel, Adrian, Bogomolov, Pavel, Viacheslav, Morozov, Stepanova, Tatyana, Lazar, Stefan, Suri, Vithika, Manuilov, Dmitry, Ye, Lei, Flaherty, John F., Osinusi, Anu, Brunetto, Maurizia, Wedemeyer, Heiner

Volltext

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D von Asselah, Tarik, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pântea, Victor, Lazar, Stefan, Placinta, Gheorghe, Gherlan, George S., Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Da, Ben L., Chee, Grace, Lau, Audrey H., Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Zoulim, Fabien

Volltext

Bulevirtide monotherapy is safe and well tolerated in patients with chronic hepatitis D (CHD): An integrated safety analysis of 48-week data von Asselah, T., Lampertico, P., Aleman, S., Bourliere, M., Streinu-Cercel, A., Bogomolov, P., Morozov, V., Stepanova, T., Lazar, S., Suri, V., Manuilov, D., Mercier, R.C., Tseng, S., Ye, L., Flaherty, J.F., Osinusi, A., Brunetto, M., Wedemeyer, H.

Volltext

Efficacy of bulevirtide as monotherapy for chronic hepatitis D (CHD): Week 48 results from an integrated analysis von Lampertico, P., Aleman, S., Blank, A., Bogomolov, P., Chulanov, V., Mamonova, N., Morozov, V., Sagalova, O., Stepanova, T., Suri, V., Manuilov, D., Ye, L., Flaherty, J.F., Osinusi, A., Cornberg, M., Brunetto, M., Wedemeyer, H.

Volltext

Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48 von Asselah, Tarik, Lampertico, Pietro, Aleman, Soo, Bourlière, Marc, Streinu-Cercel, Adrian, Bogomolov, Pavel, Morozov, Viacheslav, Stepanova, Tatiana, Lazar, Stefan, Manuilov, Dmitry, Mercier, Renee-Claude, Tseng, Steve, Ye, Lei, Flaherty, John F, Osinusi, Anu, Da, Ben L, Chee, Grace M, Lau, Audrey H, Brunetto, Maurizia R, Wedemeyer, Heiner

Volltext

In-line prediction of drug release profiles for pH-sensitive coated pellets von Pomerantsev, Alexey L, Rodionova, Oxana Ye, Melichar, Michael, Wigmore, Anthony J, Bogomolov, Andrey

Volltext

АНАЛІЗ ДІАГНОСТИЧНИХ ПАРАМЕТРІВ ІМУНОБЛОТИНГУ РІЗНИХ ВИРОБНИКІВ ДЛЯ ВИЗНАЧЕННЯ СЕНСИБІЛІЗАЦІЇ ДО ПИЛКОВИХ АЛЕРГЕНІВ У ПАЦІЄНТІВ ІЗ РЕСПІРАТОРНИМИ АЛЕРГІЧНИМИ ЗАХВОРЮВАННЯМИ... von Bogomolov, A. Ye, Zaikov, S. V.

Volltext

Formation and importance of corporate culture in the system of management von Bogomolov, A. V., Belimova, E. A., Kushekbaev, Ye. B.

Volltext

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial) von Mayevskaya, M.V., Ivashkin, V.T., Bessonova, Ye.N., Bogomolov, P.O., Geyvandova, N.I., Zhdanov, K.V., Morozov, V.G., Pasechnikov, V.D., Khomenko, I.Yu, Yagoda, A.V.

Volltext

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized plac... von V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva

Volltext